Development and Evaluation of Nevirapine Extended Release Tablets using QbD Approach

Indian Journal of Pharmaceutical Education and Research

  • Vasantakumar Pai Karkala1Department of Industrial Chemistry, Kuvempu University Shankaraghatta, B. R. Project, Shimoga-577451, Karnataka, INDIA.
  • Harsha Jinadatharaya1Department of Industrial Chemistry, Kuvempu University Shankaraghatta, B. R. Project, Shimoga-577451, Karnataka, INDIA.
  • Devagowda Vishakante Gowda2Department of Pharmaceutics, JSS Academy for Higher Education and Research, JSS College of Pharmacy, SS Nagara, Mysore.
  • Praveen Sivadasu

Volume 52 Issue 4s2 Pages s220-s228

DOI: 10.5530/ijper.52.4s.101

Abstract

Objective: To develop and evaluate Nevirapine (NVP) Extended release tablets for reducing the dosing frequency using Methylcellulose USP Methocel A15-LV and Hypromellose USP Methocel K4M Premium CR used as rate retarding polymers and Magnesium stearate as lubricant. Methods: Tablets were prepared by using roller compaction technique by employing Quality by Design (QbD) and Design of Experimentation (DoE) to study the effect of various process related parameters like Bulk density, Tapped density, Compressibility index, mesh size and in-vitro release data at 20th hour. Results: Obtained results had suggested that concentration of polymer had shown a potential effect over various process parameters and in-vitro drug release studies suggested that formulated tablets had shown a sustained release up to 24h when compared with marketed formulations. Conclusion: From the obtained results it can be concluded that formulation of Nevirapine ER Tablets employing QbD lead to a single dose per day in the management of HIV/AIDS.

Keywords

  • Quality by design
  • Nevirapine
  • Design of experimentation
  • Extended release
  • HIV/AIDS
  • Tablets
IJOPP

Loading…